CHE - Chemed Corporation
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $7.02
|
Rev Est: $659.1M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$475.00
DETAILS
HIGH:
$475.00
LOW:
$475.00
MEDIAN:
$475.00
CONSENSUS:
$475.00
UPSIDE:
1.43%
Market Cap:
6.82B
Volume:
125,885
Avg Volume:
152,111
52 Week Range:
408.42-623.61
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
0.46
Last Dividend:
$2.30
Exchange:
NYSE
Country:
US
Employees:
15,695
IPO Date:
1973-05-03
EPS (TTM):
20.10
P/E Ratio:
26.36
Revenue (TTM):
2.43B
Total Assets:
1.67B
Total Debt:
140.84M
Cash & Equiv:
178.35M
Rev Growth (5Y):
4.6%
EPS Growth (5Y):
7.9%
FCF Growth (5Y):
8.2%
ROCE:
29.0%
Debt/Equity:
0.13
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-28 | $5.27 | $5.39 | -2.2% | $624.9M | $659.0M | -5.2% |
| 2025-07-29 | $4.27 | $4.78 | -10.7% | $618.8M | $631.1M | -2.0% |
| 2025-04-23 | $5.63 | $5.55 | +1.4% | $646.9M | $641.8M | +0.8% |
| 2025-02-26 | $6.83 | $6.78 | +0.7% | $640.0M | $636.1M | +0.6% |
| 2024-10-29 | $5.64 | $5.76 | -2.1% | $606.2M | $636.1M | -4.7% |
| 2024-07-24 | $5.47 | $5.59 | -2.1% | $595.9M | $599.2M | -0.6% |
| 2024-04-24 | $5.20 | $5.48 | -5.1% | $589.2M | $591.5M | -0.4% |
| 2024-02-27 | $6.60 | $6.25 | +5.6% | $585.9M | $585.9M | 0.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.43B | 2.26B | 2.13B | 2.14B | 2.08B | 1.94B | 1.78B | 1.67B | 1.58B | 1.54B | 1.46B | 1.41B |
| Net Income | 302.00M | 272.51M | 249.62M | 268.55M | 319.47M | 219.92M | 205.54M | 98.18M | 108.74M | 110.27M | 99.32M | 77.23M |
| EPS | 20.10 | 18.11 | 16.72 | 17.14 | 20.02 | 13.77 | 12.80 | 6.11 | 6.64 | 6.54 | 5.79 | 4.24 |
| Total Assets | 1.67B | 1.67B | 1.44B | 1.34B | 1.43B | 1.27B | 975.53M | 920.03M | 880.06M | 852.33M | 859.93M | 893.70M |
| Total Debt | 140.84M | 155.11M | 247.01M | 323.54M | 135.41M | 215.94M | 89.20M | 101.20M | 108.75M | 91.25M | 147.50M | 183.56M |
| Cash & Equivalents | 178.35M | 263.96M | 74.13M | 32.90M | 162.68M | 6.16M | 4.83M | 11.12M | 15.31M | 14.73M | 14.13M | 84.42M |
| Operating Cash Flow | 417.50M | 330.30M | 309.89M | 308.60M | 489.29M | 301.25M | 287.14M | 162.50M | 135.39M | 171.50M | 110.28M | 150.85M |
| Free Cash Flow | 367.97M | 273.44M | 252.56M | 249.92M | 430.46M | 248.23M | 234.27M | 98.19M | 95.62M | 127.36M | 66.71M | 121.52M |
| FCF per Share | 24.49 | 18.17 | 16.92 | 15.95 | 26.98 | 15.54 | 14.59 | 6.12 | 5.84 | 7.55 | 3.89 | 6.68 |
| Book Value | 1.12B | 1.11B | 798.72M | 623.27M | 901.20M | 726.61M | 591.33M | 540.35M | 524.10M | 513.25M | 451.36M | 448.89M |
| Cash & ST Investments | 178.35M | 263.96M | 74.13M | 32.90M | 162.68M | 6.16M | 4.83M | 11.12M | 15.31M | 14.73M | 14.13M | 84.42M |
| ROC Equity | 0.27 | 0.25 | 0.31 | 0.43 | 0.35 | 0.30 | 0.35 | 0.18 | 0.21 | 0.21 | 0.22 | 0.17 |